Jeffrey Berkowitz

Jeffrey Berkowitz

Director/Board Member bei BRAEBURN INC.

Vermögen: 873 541 $ am 31.03.2024

58 Jahre
Health Technology
Commercial Services
Technology Services

Profil

Jeffrey Berkowitz is currently the Chief Executive Officer & Director at Real Endpoints LLC.
He is also the Chairman at Pharma Two B Ltd.
Additionally, he serves as an Independent Director at H.
Lundbeck A, Director at Click Therapeutics, Inc., Independent Director at Zealand Pharma A, Director at Braeburn, Inc., Senior Advisor at Permira Advisers LLP, and Venture Advisor at Israel Biotech Fund.
In his former positions, Mr. Berkowitz served as an Independent Director at Esperion Therapeutics, Inc. from 2017 to 2023.
He was also an Independent Director at Infinity Pharmaceuticals, Inc. from 2014 to 2020.
He held the position of Director at Swiss-American Chamber of Commerce, Aptus Health, Inc., Physicians Interactive Holdings LLC, ZappRx, Inc., and UnitedHealth Group, Inc. He was the Senior Vice President-Global Market Access at Merck & Co., Inc. and Vice President-Global Market Access at Schering-Plough Corp.
He served as the Executive Vice President at UnitedHealth Group, Inc., InGensa, Inc., and Optum, Inc. He was the SVP-Pharmaceutical Development & Market Access at Walgreen Co. and EVP, President-Pharma & Global Market Access at Walgreens Boots Alliance, Inc. He was also the Co-President at Walgreens Boots Alliance Development GmbH.
Mr. Berkowitz received his undergraduate degree from Union College (New York) and his graduate degree from Brooklyn Law School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.12.2023 8 200 ( 0,01% ) 810 698 $ 31.03.2024
28.03.2023 23 449 ( 0,01% ) 62 843 $ 31.03.2024

Aktive Positionen von Jeffrey Berkowitz

UnternehmenPositionBeginn
H. LUNDBECK A/S Director/Board Member 20.03.2018
ZEALAND PHARMA A/S Director/Board Member 04.04.2019
BRAEBURN INC. Director/Board Member 01.12.2017
Consultant / Advisor -
Director/Board Member -
Chairman 12.08.2021
Chief Executive Officer 13.09.2018
Consultant / Advisor 08.11.2023
Alle aktiven Positionen von Jeffrey Berkowitz

Ehemalige bekannte Positionen von Jeffrey Berkowitz

UnternehmenPositionEnde
UNIPHAR PLC Director/Board Member 16.01.2024
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Jeffrey Berkowitz im Detail an

Ausbildung von Jeffrey Berkowitz

Union College (New York) Undergraduate Degree
Brooklyn Law School Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jeffrey Berkowitz im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

26

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen8
MERCK & CO., INC.

Health Technology

UNITEDHEALTH GROUP INC.

Health Services

ESPERION THERAPEUTICS, INC.

Health Technology

H. LUNDBECK A/S

Health Technology

INFINITY PHARMACEUTICALS, INC.

Health Technology

ZEALAND PHARMA A/S

Health Technology

WALGREENS BOOTS ALLIANCE, INC.

Retail Trade

UNIPHAR PLC

Distribution Services

Private Unternehmen16

Health Technology

Retail Trade

Technology Services

Finance

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Technology Services

Commercial Services

Health Technology

Finance

Commercial Services

Technology Services

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Jeffrey Berkowitz